acetylcysteine has been researched along with mivacurium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Amann, A; Amberger, A; Fleischer, M; Hoffmann, G; Marth, C; Niedermüller, P; Nigrovic, V; Pühringer, F; Rieder, J | 1 |
1 review(s) available for acetylcysteine and mivacurium
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for acetylcysteine and mivacurium
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
The influence of atracurium, cisatracurium, and mivacurium on the proliferation of two human cell lines in vitro.
Topics: Acetylcysteine; Atracurium; Carboxylic Ester Hydrolases; Carcinoma, Hepatocellular; Cell Count; Cell Division; Cell Line; Endothelium, Vascular; Free Radical Scavengers; Glutathione; Humans; Isoquinolines; Liver Neoplasms; Mivacurium; Neuromuscular Nondepolarizing Agents | 2001 |